Skip to main content
BioCardia, Inc. logo

BioCardia, Inc. — Investor Relations & Filings

Ticker · BCDA ISIN · US09060U5074 LEI · 5493003EDBXRQRW22O75 US Manufacturing
Open in API
Filings indexed 1,023 across all filing types
Latest filing 2018-02-05 Director's Dealing
Country US United States of America
Listing US BCDA

About BioCardia, Inc.

https://www.biocardia.com/

BioCardia, Inc. is a clinical-stage regenerative medicine company that develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. The company's lead program is the CardiAMP® cell therapy system, an autologous therapy that uses a patient's own bone marrow cells to potentially stimulate the body's natural healing response in the heart. This therapy is primarily being evaluated for the treatment of ischemic heart failure. In addition to its autologous platform, BioCardia is also developing CardiALLO™, an allogeneic cell therapy platform using cells from qualified donors. The company's approach integrates biotherapeutic candidates with proprietary delivery systems for targeted administration.

Recent filings

Filing Released Lang Actions
FORM 4/A
Director's Dealing
2018-02-05 English
FORM 10-Q
Interim / Quarterly Report Q3 2017
2017-11-09 English
FORM 8-K
Share Issue/Capital Change Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details a 12-for-1 reverse stock split of the company's common stock, including the filing of a Certificate of Amendment with the Delaware Secretary of State, effective dates, and trading symbol changes. This is a capital structure change event. The document does not contain financial statements or detailed financial analysis but announces a corporate action affecting the capital stock. According to the filing definitions, announcements regarding stock splits or other capital changes fall under 'Share Issue/Capital Change' (SHA). The document length is about 5928 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the correct classification is SHA with high confidence.
2017-11-07 English
FORM DEF 14C
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14C Information Statement filed pursuant to Section 14(c) of the Securities Exchange Act of 1934. It is a definitive information statement notifying stockholders of a reverse stock split approved by written consent of majority stockholders, without a stockholder meeting or proxy solicitation. The document details the reverse stock split, its purpose, effects, and procedural information. It is not a proxy solicitation, voting results announcement, or a financial report. The document is a formal communication to shareholders about a corporate action requiring no vote, consistent with the definition of a Proxy Solicitation & Information Statement (PSI).
2017-10-10 English
FORM 4
Director's Dealing
2017-10-05 English
FORM PRE 14C
Share Issue/Capital Change Classification · 95% confidence The document is a Schedule 14C Information Statement filed pursuant to Section 14(c) of the Securities Exchange Act of 1934. It details a corporate action approved by written consent of majority stockholders to effectuate a 12-to-1 reverse stock split. The document is not a proxy solicitation, nor a meeting notice, but an information statement informing shareholders of the reverse stock split and related procedural and tax information. The content focuses on a capital structure change (reverse stock split) and shareholder notification thereof. This fits the definition of a Share Issue/Capital Change announcement, as it relates to a stock split and capital restructuring. The document is substantive and not merely an announcement of a report or a certification. Therefore, the appropriate classification is SHA (Share Issue/Capital Change). Confidence is high given the clear description and regulatory form type (Schedule 14C) related to capital changes.
2017-09-26 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.